PGEJX
Price
$27.80
Change
+$0.20 (+0.72%)
Updated
Sep 4 closing price
Net Assets
2.25B
RLBAX
Price
$37.59
Change
+$0.20 (+0.53%)
Updated
Sep 5 closing price
Net Assets
257.73B
Interact to see
Advertisement

PGEJX vs RLBAX

Header iconPGEJX vs RLBAX Comparison
Open Charts PGEJX vs RLBAXBanner chart's image
George Putnam Balanced R6
Price$27.80
Change+$0.20 (+0.72%)
VolumeN/A
Net Assets2.25B
American Funds American Balanced R1
Price$37.59
Change+$0.20 (+0.53%)
VolumeN/A
Net Assets257.73B
PGEJX vs RLBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGEJX vs. RLBAX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEJX is a Buy and RLBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 258B vs. PGEJX (2.25B). PGEJX pays higher dividends than RLBAX: PGEJX (1.72) vs RLBAX (1.15). PGEJX was incepted earlier than RLBAX: PGEJX (12 years) vs RLBAX (23 years). RLBAX (1.31) is less costly to investors than PGEJX (0.61). PGEJX is a more actively managed with annual turnover of: 80.00 vs. RLBAX (44.00). PGEJX has a lower initial minimum investment than RLBAX: PGEJX (0) vs RLBAX (250). PGEJX annual gain was more profitable for investors over the last year : 10.15 vs. RLBAX (9.12). RLBAX return over 5 years is better than : 35.40 vs. PGEJX (33.32).
PGEJXRLBAXPGEJX / RLBAX
Total Expense Ratio0.611.3147%
Annual Report Gross Expense Ratio0.611.3147%
Fund Existence12 years23 years-
Gain YTD9.01710.80583%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.25B258B1%
Annual Yield % from dividends1.721.15149%
Returns for 1 year10.159.12111%
Returns for 3 years45.1437.15122%
Returns for 5 years33.3235.4094%
Returns for 10 years95.2967.71141%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNLI15.430.64
+4.33%
Denali Therapeutics
AUNA6.36N/A
N/A
Auna SA
QNRX7.56-0.06
-0.85%
Quoin Pharmaceuticals Ltd
STN108.05-1.24
-1.13%
Stantec
FATN5.86-0.29
-4.72%
FatPipe Inc.